Diagnostic potential of tetramer-based monitoring of cytomegalovirus-specific CD8+ T lymphocytes in allogeneic stem cell transplantation

Clinical Immunology

Volumn 106, Issue 1, 2003, Pages 29-35

  Gratama, J W ^a   Cornelissen, J J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Allogeneic stem cell transplantation; Cytomegalovirus; Flow cytometry; Immune reconstitution; T lymphocyte; Tetramer

Indexed keywords

CD8 ANTIGEN; CYTOMEGALOVIRUS ANTIBODY; GANCICLOVIR; TETRAMER;

ANTIGEN SPECIFICITY; ARTICLE; CELL SPECIFICITY; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC TEST; FLOW CYTOMETRY; HUMAN; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; T LYMPHOCYTE; TECHNIQUE;

EID: 0037288497     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/S1521-6616(02)00019-0     Document Type: Article

References (61)

1. Thomas E.D., Blume K.G., Forman S.J. (Eds.) Hematopoietic Cell Transplantation. 2nd ed. 1999;Blackwell Sci, Malden.
2. + cells from healthy subjects carry a circular conformation of latent cytomegalovirus genome. Blood. 93:1999;394-398.
3. Reddehase M.J., Weiland F., Munch K., Jonjic S., Luske A., Koszinowski U.H. Interstitial murine cytomegalovirus pneumonia after irradiation Characterization of cells that limit viral replication during established infection of the lungs . J. Virol. 55:1985;264-273.
4. Quinnan G.V. Jr., Kirmani N., Rook A.H., Manischewitz J.F., Jackson L., Moreschi G., Santos G.W., Saral R., Burns W.H. Cytotoxic T cells in cytomegalovirus infection Recovery from cytomegalovirus infection in bone marrow transplant recipients . N. Engl. J. Med. 307:1982;6-13.
5. Boéckh M.J., Ljungman P. Cytomegalovirus infection after BMT. Bowden R.A., Ljungman P., Paya C.V. Transplant Infections. 1998;215-227 Lippincott-Raven, Philadelphia.
6. Goodrich J.M., Bowden R.A., Fisher L., Keller C., Schoch G., Meyers J.D. Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant. Ann. Intern. Med. 118:1993;173-178.
7. Winston D.J., Ho W.G., Bartoni K., Du Mond C., Ebeling D.F., Buhles W.C., Champlin R.E. Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients Results of a placebo-controlled, double-blind trial . Ann. Intern. Med. 118:1993;179-184.
8. Boeckh M., Gooley T.A., Myerson D., Cunningham T., Schoch G., Bowden R.A. Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation A randomized double-blind study . Blood. 88:1996;4063-4071.
9. Schmidt G.M., Horak D.A., Niland J.C., Duncan S.R., Forman S.J., Zaia J.A. A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants. N. Engl. J. Med. 324:1991;1005-1011.
10. Goodrich J.M., Mori M., Gleaves C.A., Du Mond C., Cays M., Ebeling D.F., Buhles W.C., DeArmond B., Meyers J.D. Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation. N. Engl. J. Med. 325:1991;1601-1607.
11. Einsele H., Hebart H., Kauffmann-Schneider C., Sinzger C., Jahn G., Bader P., Klingebiel T., Dietz K., Löffler J., Bokemeyer C., Kanz L., Müller C.A. Risk factors for treatment failures in patients receiving PCR-based pre-emptive therapy for CMV infection. Bone Marrow Transplant. 25:2000;757-763.
12. Zaia J.A., Gallez-Hawkins G.M., Tegtmeier B.R., Ter Veer A., Li X., Niland J.C., Forman S.J. Late cytomegalovirus disease in marrow transplantation is predicted by virus load in plasma. J. Infect. Dis. 176:1997;782-785.
13. Reusser P., Riddell S.R., Meyers J.D., Greenberg P.D. Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation Pattern of recovery and correlation with cytomegalovirus infection and disease . Blood. 78:1991;1373-1380.
14. Li C.R., Greenberg P.D., Gilbert M.J., Goodrich J.M., Riddell S.R. Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant Correlation with CMV disease and effect of ganciclovir prophylaxis . Blood. 83:1994;1971-1979.
15. Wills M.R., Carmichael A.J., Mynard K., Jin X., Weekes M.P., Plachter B., Sissons J.G.P. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65 Frequency, specificity and T-cell receptor usage of pp65-specific CTL . J. Virol. 70:1996;7569-7579.
16. + T lymphocytes secreting tumor necrosis factor alpha in response to HLA-A2-1-binding melanoma and viral peptide antigens. J. Immunol. Methods. 191:1996;131-142.
17. + T cell frequencies by flow cytometry Evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency . J. Clin. Invest. 99:1997;1739-1750.
18. + T-cell frequencies by flow cytometry. Blood. 94:1999;3094-3100.
19. Kern F., Faulhaber N., Frömmel C., Khatamzas E., Prösch S., Schönemann C., Kretzschmar I., Volkmer-Engert R., Volk H.D., Reinke P. Analysis of CD8 T cell reactivity to cytomegalovirus using protein-spanning pools of overlapping pentadecapeptides. Eur. J. Immunol. 30:2000;1676-1682.
20. Kern F., Bunde T., Faulhaber N., Kiecker F., Khatamzas E., Rudawski I.M., Pruss A., Gratama J.W., Volkmer-Engert R., Ewert R., Reinke P., Volk H.D., Picker L.J. Cytomegalovirus (CMV) prosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals. J. Infect. Dis. 185:2002;1709-1716.
21. Altman J., Moss P.A.H., Goulder P., Barouch D., McHeyzer-Williams M., Bell J.I., McMichael A.J., Davis M.M. Direct visualization and phenotypic analysis of virus-specific T lymphocytes in HIV-infected individuals. Science. 274:1996;94-96.
22. Gratama J.W., Cornelissen J.J. Potential clinical utility of monitoring cytomegalovirus-specific T lymphocytes in allogeneic stem cell transplantation. Clin. Appl. Immunol. Rev. 2:2001;17-32.
23. + T cells proliferating in response to influenza antigen. J. Clin. Invest. 104:1999;R63-R67.
24. Rammensee H.G., Bachmann J., Emmerich N.P., Bachor O.A., Stevanovic S. SYFPEITHI Database for MHC ligands and peptide motifs . Immunogenetics. 50:1999;213-219.
25. Schumacher T.N.M., Van Bleek G.M., Heemels M., Deres K., Li K.W., Imarai M., Vernie L.N., Nathenson S.G., Ploegh H.L. Synthetic peptide libraries in the determination of T cell epitopes and peptide binding specificity of class I molecules. Eur. J. Immunol. 22:1992;1405-1412.
26. Van der Burg S., Ras E., Drijfhout J., Benkuijsen W., Bremers A.J., Melief C., Kast W. An HLA class I peptide-binding assay based on competition for binding to class I molecules on intact human B-cells Identification of conserved HIV-1 polymerase peptides binding to HLA-A * 0301 . Hum. Immunol. 44:1995;189-198.
27. Kern F., Surel I.P., Brock C., Freistedt B., Radtke H., Scheffold A., Blasczyk R., Reinke P., Schneider-Mergener J., Radbruch A., Walden P., Volk H.D. T-cell epitope mapping by flow cytometry. Nat. Med. 4:1998;975-978.
28. + virus-specific cytotoxic T lymphocytes. J. Med. Virol. 43:1994;103-110.
29. Boppana S.B., Britt W.J. Recognition of human cytomegalovirus gene products by HCMV-specific cytotoxic T cells. Virology. 222:1996;293-296.
30. +-T-cell response to human cytomegalovirus The 72-kilodalton major immediate-early protein revisited . J. Virol. 73:1999;8179-8184.
31. Longmate J., York J., La Rosa C., Krishnan R., Zhang M., Senitzer D., Diamond D.J. Population coverage by HLA class-I restricted cytotoxic T-lymphocyte epitopes. Immunogenetics. 52:2001;165-173.
32. Solache A., Morgan C.L., Dodi A.I., Morte C., Scott I., Baboonian C., Zal B., Goldman J., Grundy J.E., Madrigal J.A. Identification of three HLA-A * 0201-restricted cytotoxic T cell epitopes in the cytomegalovirus protein pp65 that are conserved between eight strains of the virus. J. Immunol. 163:1999;5512-5518.
33. Weekes M.P., Wills M.R., Mynard K., Carmichael A.J., Sissons J.P.G. The memory cytotoxic T-lymphocyte (CTL) response to human cytomegalovirus infection contains individual peptide-specific CTL clones that have undergone extensive expansion in vivo. J. Virol. 73:1999;2099-2108.
34. + T-cell epitopes by a computer algorithm and an enzyme-linked immunospot assay. Blood. 98:2001;1872-1881.
35. Masuoka M., Yoshimuta T., Hamada M., Okamoto M., Fumimori T., Honda J., Oizumi K., Itoh K. Identification of the HLA-A24 peptide epitope within cytomegalovirus protein pp65 recognized by CMV-specific cytotoxic T lymphocytes. Viral Immunol. 14:2001;369-377.
36. Gavin M.A., Gilbert M.J., Riddell S.R., Greenberg P.D., Bevan M.J. Alkali hydrolysis of recombinant proteins allows for the rapid identification of class I MHC-restricted CTL epitopes. J. Immunol. 151:1993;3971-3980.
37. Retière C., Prod'homme V., Imbert-Marcille B.M., Bonneville M., Vié H., Hallet M.M. Generation of cytomegalovirus-specific human T-lymphocyte clones by using autologous B-lymphoblastoid cells with stable expression of pp65 or IE1 proteins A tool to study the fine specificity of the antiviral response . J. Virol. 74:2000;3948-3952.
38. Aubert G., Hassan-Walker A.F., Madrigal J.A., Emery V.C., Morte C., Grace S., Koh M.B.C., Potter M., Prentice H.G., Dodi I.A., Travers P. Cytomegalovirus-specific cellular immune responses and viremia in recipients of allogeneic stem cell transplants. J. Infect. Dis. 184:2001;955-963.
39. Cwynarski K., Ainsworth J., Cobbold M., Wagner S., Mahendra P., Apperley J., Goldman J., Craddock C., Moss P.A.H. Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation. Blood. 97:2001;1232-1240.
40. Einsele H., Roosnek E., Rufer N., Sinzger C., Riegler S., Löffler J., Grigoleit U., Moris A., Rammensee H.G., Kanz L., Kleihauer A., Frank F., Jahn G., Hebart H. Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy. Blood. 99:2002;3916-3922.
41. + T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection. Blood. 98:2001;1358-1364.
42. Benz C., Utermöhlen O., Wulf A., Villmow B., Dries V., Goeser T., Koszinowski U., Busch D.H. Activated virus-specific T cells are early indicators of anti-CMV immune reactions in liver transplant patients. Gastroenterology. 122:2002;1201-1215.
43. Chen G., Shankar P., Lange C., Valdez H., Skolnik P.R., Wu L., Manjunath N., Lieberman J. CD8 T cells specific for human immunodeficiency virus, Epstein-Barr virus and, cytomegalovirus lack molecules for homing to lymphoid sites of infection. Blood. 98:2001;156-164.
44. + cytotoxic lymphocyte responses against cytomegalovirus after liver transplantation Correlation with time from transplant to receipt of tacrolimus . J. Infect. Dis. 183:2001;843-843.
45. + T lymphocytes using MHC tetramers in kidney transplant patients and healthy participants. Transplantation. 69:2000;2243-2250.
46. Bodinier M., Peyrat M.A., Tournay C., Davodeau F., Romagné F., Bonneville M., Lang F. Efficient detection and immunomagnetic sorting of specific T cells using multimers of MHC class I and peptide with reduced CD8 binding. Nat. Med. 6:2000;707-710.
47. + T lymphocytes in healthy seropositive donors. J. Virol. 74:2000;8140-8150.
48. Jin X., Demoitie M.A., Donahoe S.M., Ogg G.S., Bonhoeffer S., Kakimoto W.M., Gillespie G., Moss P.A., Dyer W., Kurilla M.G., Riddell S.R., Downie J., Sullivan J.S., McMichael A.J., Workman C., Nixon D.F. High frequency of cytomegalovirus-specific cytotoxic T-effector cells in HLA-A * 0201-positive subjects during multiple viral coinfections. J. Infect. Dis. 181:2000;165-175.
49. Keenan R.D., Ainsworth J., Khan N., Bruton R., Cobbold M., Assenmacher M., Milligan D.W., Moss P.A.H. Purification of cytomegalovirus-specific CD8 T cells from peripheral blood using HLA-peptide tetramers. Br. J. Haematol. 115:2001;428-434.
50. + T cell responses against human cytomegalovirus proteins pp65 and immediate early 1 shows similarities in precursor frequency, oligoclonality, and phenotype. J. Infect. Dis. 185:2002;1025-1034.
51. + T cells. J. Virol. 74:2000;1018-1022.
52. Szmania S., Galloway A., Bruorton M., Musk P., Aubert G., Arthur A., Pyle H., Hensel N., Ta N., Lamb L. Jr., Dodi T., Madrigal A., Barrett J., Henslee-Downey J., Van Rhee F. Isolation and expansion of cytomegalovirus-specific cytotoxic T lymphocytes to clinical scale from a single blood draw using dendritic cells and HLA-tetramers. Blood. 98:2001;505-512.
53. + T cells from peripheral blood mononuclear cells of human cytomegalovirus-seropositive blood donors by using a soluble recombinant chimeric protein, IE1-pp65. J. Virol. 75:2001;7840-7847.
54. + cytotoxic T-lymphocytes in liver transplant recipients. Transplantation. 69:2000;2251-2259.
55. Krause H., Hebart H., Jahn G., Müller C.A., Einsele H. Screening for CMV-specific T cell proliferation to identify patients at risk of developing late onset CMV disease. Bone Marrow Transplant. 19:1997;1111-1116.
56. Ljungman P., Aschan J., Azinge J.N., Brandt L., Ehrnst A., Hammarström V., Klaesson S., Linde A., Lönnqvist B., Ringdén B., Wahren B., Gahrton G. Cytomegalovirus viremia and specific T-helper cell responses as predictors of disease after allogeneic marrow transplantation. Br. J. Haematol. 83:1993;118-124.
57. Hebart H., Daginik S., Stevanovic S., Grigoleit U., Dobler A., Baur M., Rauser G., Sinzger C., Jahn G., Loeffler J., Kanz L., Rammensee H.G., Einsele H. Sensitive detection of human cytomegalovirus peptide-specific cytotoxic T-lymphocyte responses by interferon-γ-enzyme-linked immunospot assay and flow cytometry in healthy individuals and in patients after allogeneic stem cell transplantation. Blood. 99:2002;3830-3837.
58. + T cell counts. Am. J. Hematol. 54:1997;131-138.
59. Small T.N., Papadopoulos E.B., Boulad F., Black P., Castro-Malaspina H., Childs B.H., Collins N., Gillio A., George D., Jakubowski A., Heller G., Fazzari M., Kernan N., MacKinnon S., Szabolcs P., Young J.W., O'Reilly R.J. Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation Effect of patient age and donor leukocyte infusions . Blood. 93:1999;467-480.
60. Walter E.A., Greenberg P.D., Gilbert M.J., Finch R.J., Watanabe K.S., Thomas E.D., Riddell S.R. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N. Engl. J. Med. 333:1995;1038-1044.
61. Schipper R.F., Van Els C.A.C.M., D'Amaro J., Oudshoorn M. Minimal phenotype panels A method for achieving maximum population coverage with a minimum of HLA antigens . Hum. Immunol. 51:1996;95-98.